Literature DB >> 30859755

Home-Based Exercise in Patients Awaiting Liver Transplantation: A Feasibility Study.

Felicity Rhian Williams1,2, Alice Vallance2, Thomas Faulkner3, Jennifer Towey4, Simon Durman5, Derek Kyte1,6, Ahmed Mohamed Elsharkawy1,7, Thamara Perera7, Andrew Holt1,7, James Ferguson1,7, Janet M Lord1,8, Matthew James Armstrong1,7.   

Abstract

Frailty is associated with increased mortality both before and after liver transplantation (LT). There are no standardized exercise programs, in particular home-based exercise programs (HBEPs), for patients awaiting LT. The aim was to investigate the feasibility of such a program in patients awaiting LT. Patients were randomly selected from the Birmingham LT waiting list and provided with a 12-week HBEP, including average daily step (ADS) targets and twice-weekly resistance exercises. Feasibility was based on patient eligibility (≥66% of waiting list), target recruitment (≥90% of n = 20), safety (no related serious adverse events), and adherence (≥66% adherence to 6-week HBEP). Measures of aerobic (incremental shuttle walk test [ISWT], ADS), functional capacity (short physical performance battery test [SPPBT]), and health-related quality of life (EuroQol 5-Dimension 5-Level (EQ-5D-5L) and hospital anxiety and depression score [HADS]) were taken at baseline and at 6 and 12 weeks. 18 patients (50% male; median age, 55 years) were recruited. All domains of the study feasibility criteria were met. ISWT improved after 6 weeks (50 m; P ≤ 0.01) and 12 weeks (210 m; P ≤ 0.01), despite withdrawal of the telephone health calls. Similarly, improvements were seen in ADS (2700/day; P ≤ 0.01) and the SPPBT (2.5; P = 0.02) after 12 weeks. There was no difference in HADS (median difference [MD] -3; P = 0.69), but EQ-5D-5L after 12 weeks (17.5%; P = 0.04). In conclusion, a 12-week HBEP, incorporating both easy-to-apply resistance and aerobic exercises, is safe and feasible in patients awaiting LT. Measures of aerobic and functional capacity demonstrate trends toward improvement that warrant further investigation in a randomized controlled trial.
Copyright © 2019 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2019        PMID: 30859755     DOI: 10.1002/lt.25442

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  14 in total

1.  Recent advances in liver transplantation.

Authors:  N Thomas Burke; James B Maurice; David Nasralla; Jonathan Potts; Rachel Westbrook
Journal:  Frontline Gastroenterol       Date:  2021-04-21

2.  Cognitive impairment in candidates for allogeneic hematopoietic stem cell transplantation.

Authors:  Patrick J Smith; Meagan Lew; Yen Lowder; Kristi Romero; Jillian C Thompson; Lauren Bohannon; Alyssa Pittman; Alexandra Artica; Sendhilnathan Ramalingam; Taewoong Choi; Cristina Gasparetto; Mitchell Horwitz; Gwynn Long; Richard Lopez; David Rizzieri; Stefanie Sarantopoulos; Keith Sullivan; Nelson Chao; Anthony D Sung
Journal:  Bone Marrow Transplant       Date:  2021-10-19       Impact factor: 5.483

3.  Physical Activity Patterns in Frail and Nonfrail Patients With End-Stage Liver Disease.

Authors:  Shirley Handelzalts; Michael Volk; Jessica D Zendler; Cristine Agresta; Jillian Peacock; Neil B Alexander
Journal:  J Clin Exp Hepatol       Date:  2021-10-23

4.  Face-to-Face Mentoring, Remotely Supervised Home Exercise Prehabilitation to Improve Physical Function in Patients Awaiting Kidney Transplantation: A Randomized Clinical Trial.

Authors:  Xiaojie Ma; Zaozhang Zhang; Mengsi Peng; Bonuan Yao; Hongtao Jiang; Xuanfu Ji; Yong You
Journal:  Front Psychol       Date:  2022-06-16

5.  Pragmatic solutions to enhance self-management skills in solid organ transplant patients: systematic review and thematic analysis.

Authors:  Hamidreza Abtahi; Reza Safdari; Marsa Gholamzadeh
Journal:  BMC Prim Care       Date:  2022-06-30

6.  Resistance Training Reduces Risk of Sarcopenia in Patients With Cirrhosis.

Authors:  Puneeta Tandon; Michael A Dunn; Andres Duarte-Rojo
Journal:  Clin Gastroenterol Hepatol       Date:  2019-10-04       Impact factor: 11.382

Review 7.  Lifestyle modification in NAFLD/NASH: Facts and figures.

Authors:  Kate Hallsworth; Leon A Adams
Journal:  JHEP Rep       Date:  2019-11-05

8.  Telehealth-delivered, Cardioprotective Diet and Exercise Program for Liver Transplant Recipients: A Randomized Feasibility Study.

Authors:  Ingrid J Hickman; Amy K Hannigan; Heidi E Johnston; Louise Elvin-Walsh; Hannah L Mayr; Heidi M Staudacher; Amandine Barnett; Rachel Stoney; Chloe Salisbury; Maree Jarrett; Marina M Reeves; Jeff S Coombes; Katrina L Campbell; Shelley E Keating; Graeme A Macdonald
Journal:  Transplant Direct       Date:  2021-02-04

Review 9.  Nutrition in Chronic Liver Disease: Consensus Statement of the Indian National Association for Study of the Liver.

Authors:  Pankaj Puri; Radha K Dhiman; Sunil Taneja; Puneeta Tandon; Manuela Merli; Anil C Anand; Anil Arora; Subrat K Acharya; Jaya Benjamin; Yogesh K Chawla; Sunil Dadhich; Ajay Duseja; C E Eapan; Amit Goel; Naveen Kalra; Dharmesh Kapoor; Ashish Kumar; Kaushal Madan; Aabha Nagral; Gaurav Pandey; Padaki N Rao; Sanjiv Saigal; Neeraj Saraf; Vivek A Saraswat; Anoop Saraya; Shiv K Sarin; Praveen Sharma; Akash Shukla; Sandeep S Sidhu; Namrata Singh; Shivaram P Singh; Anshu Srivastava; Manav Wadhawan
Journal:  J Clin Exp Hepatol       Date:  2020-10-01

Review 10.  Assessment of the Frail Patient With End-Stage Liver Disease: A Practical Overview of Sarcopenia, Physical Function, and Disability.

Authors:  Felicity R Williams; Don Milliken; Jennifer C Lai; Matthew J Armstrong
Journal:  Hepatol Commun       Date:  2021-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.